Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Alexander Kohlmann, Jeffrey Gordon

Premium

Alexander Kohlmann is now director of bioscience at AstraZeneca. Previously, he was headed up the department of next-generation sequencing and microarrays at the Munich Leukemia Laboratory. Before that, he was research alliance manager at Roche Diagnostics.


Jeffrey Gordon, director of Washington University School of Medicine's Center for Genome Sciences and Systems Biology has won the 2014 Passano Foundation Award for his work demonstrating how gut microbes influence human health.

Gordon joined Wash U's School of Medicine in 1981. He is a member of the National Academy of Sciences, the American Academy of Arts and Sciences, and the Institute of Medicine of the National Academies.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.